Lantheus Holdings Inc. (LNTH) Shares Down 6.7%
Lantheus Holdings Inc. (NASDAQ:LNTH) shares fell 6.7% during trading on Tuesday . The company traded as low as $6.80 and last traded at $7.07, with a volume of 226,365 shares trading hands. The stock had previously closed at $7.58.
A number of brokerages have recently commented on LNTH. Zacks Investment Research cut Lantheus Holdings from a “buy” rating to a “hold” rating in a research report on Thursday, May 12th. Jefferies Group reaffirmed a “buy” rating on shares of Lantheus Holdings in a research report on Wednesday, May 4th. Finally, Credit Suisse Group AG set a $4.00 price target on Lantheus Holdings and gave the company a “hold” rating in a research report on Friday, August 5th. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $5.80.
The stock has a 50 day moving average price of $4.85 and a 200 day moving average price of $2.84. The company has a market cap of $215.75 million and a price-to-earnings ratio of 8.01.
Lantheus Holdings (NASDAQ:LNTH) last posted its quarterly earnings data on Thursday, August 4th. The company reported $0.24 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.18. The company had revenue of $78 million for the quarter, compared to the consensus estimate of $72.66 million. Equities analysts expect that Lantheus Holdings Inc. will post $0.53 earnings per share for the current fiscal year.
Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.